logo
Plus   Neg
Share
Email

Flex Pharma To Close FLX-787 Phase 2 Trials; To Assess Strategic Alternatives

Flex Pharma, Inc. (FLKS) announced that the company is ending its ongoing Phase 2 clinical trial investigations of FLX-787 in amyotrophic lateral sclerosis and Charcot-Marie-Tooth due to oral tolerability concerns observed in both studies, in a subset of patients being treated.

Flex Pharma announced the company will restructure its organization to reduce costs, including reducing its workforce by approximately 60 percent. The company's Board and its management are in alignment that the company's best path forward to preserve stockholder value is to focus its resources on assessing strategic alternatives, including the potential sale or merger of the company. The Board has established a Strategic Committee that will work with management to oversee the process.

The company said it will continue to operate with a reduced internal team that will focus efforts on assessing the potential of FLX-787 in dysphagia and operating the HOTSHOT consumer business while the strategic review is ongoing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM) announced plans to invest $391 million at its pickup truck assembly plant in San Antonio, Texas. The investment is part of the Japanese automaker's plan to invest $13 billion in its U.S. operations over five years through 2021. The company said the investment will be used... Virgin Atlantic is set to challenge British Airways' dominance at London Heathrow as the carrier announced plans to fly to 84 new destinations from the airport when its third runway is opened. Chief Executive Shai Weiss said, "Heathrow has been dominated by one airline group for far too long. The... Walmart (WMT) on Wednesday announced that it is teaming up with Capital One to roll out two new credit cards designed to compete with cards from Apple and Amazon. The companies said the Capital One Walmart Rewards Credit Card Program with two new cards will launch on September 24. The program's Mastercard...
Follow RTT